Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Current status and future potential of advanced technologies in radiation oncology. Part 1. Challenges and resources.

Vikram B, Coleman CN, Deye JA.

Oncology (Williston Park). 2009 Mar;23(3):279-83. Review.

2.

INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.

[No authors listed]

Drugs R D. 2007;8(3):176-87. Review.

PMID:
17472413
3.

Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.

[No authors listed]

Drugs R D. 2005;6(3):178-85. Review.

PMID:
15869322
4.

Technology for Innovation in Radiation Oncology.

Chetty IJ, Martel MK, Jaffray DA, Benedict SH, Hahn SM, Berbeco R, Deye J, Jeraj R, Kavanagh B, Krishnan S, Lee N, Low DA, Mankoff D, Marks LB, Ollendorf D, Paganetti H, Ross B, Siochi RA, Timmerman RD, Wong JW.

Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):485-92. doi: 10.1016/j.ijrobp.2015.07.007.

5.

Intensity-modulated radiotherapy: current status and issues of interest.

Intensity Modulated Radiation Therapy Collaborative Working Group..

Int J Radiat Oncol Biol Phys. 2001 Nov 15;51(4):880-914. Review.

PMID:
11704310
6.

Radiation oncology research in the cancer and leukemia group B.

Bogart JA, Seagren SL, Glicksman A.

Clin Cancer Res. 2006 Jun 1;12(11 Pt 2):3628s-34s. Review.

7.

Imaging in radiation oncology: a perspective.

Dawson LA, Ménard C.

Oncologist. 2010;15(4):338-49. doi: 10.1634/theoncologist.2009-S106. Review.

8.
9.

Hyperthermic treatment of malignant diseases: current status and a view toward the future.

Dewhirst MW, Prosnitz L, Thrall D, Prescott D, Clegg S, Charles C, MacFall J, Rosner G, Samulski T, Gillette E, LaRue S.

Semin Oncol. 1997 Dec;24(6):616-25. Review.

PMID:
9422258
10.

Quality assurance needs for modern image-based radiotherapy: recommendations from 2007 interorganizational symposium on "quality assurance of radiation therapy: challenges of advanced technology".

Williamson JF, Dunscombe PB, Sharpe MB, Thomadsen BR, Purdy JA, Deye JA.

Int J Radiat Oncol Biol Phys. 2008;71(1 Suppl):S2-12. doi: 10.1016/j.ijrobp.2007.08.080.

PMID:
18406928
11.

[Coming technical advances in radiation oncology].

Suit H.

Z Med Phys. 2005;15(4):215-27. Review. German.

PMID:
16422350
12.

Radiation oncology in the third millennium.

Brady LW, Levitt SH.

Rays. 1999 Jul-Sep;24(3):361-72. Review. English, Italian.

PMID:
10605296
13.

Emergent technologies for 3-dimensional image-guided radiation delivery.

Jaffray DA.

Semin Radiat Oncol. 2005 Jul;15(3):208-16. Review.

PMID:
15983946
14.

Biological basis of radiation sensitivity. Part 1: Factors governing radiation tolerance.

Rosen EM, Fan S, Goldberg ID, Rockwell S.

Oncology (Williston Park). 2000 Apr;14(4):543-50. Review.

15.

Comparative effectiveness research in radiation oncology: assessing technology.

Chen AB.

Semin Radiat Oncol. 2014 Jan;24(1):25-34. doi: 10.1016/j.semradonc.2013.08.003. Review.

PMID:
24314339
16.

Intraoperative irradiation: current and future status.

Gunderson LL, Willett CG, Harrison LB, Petersen IA, Haddock MG.

Semin Oncol. 1997 Dec;24(6):715-31. Review.

PMID:
9422267
17.

Radiation therapy.

Jeremic B.

Hematol Oncol Clin North Am. 2004 Feb;18(1):1-12. Review.

PMID:
15005277
18.

Overview of image-guided radiation therapy.

Xing L, Thorndyke B, Schreibmann E, Yang Y, Li TF, Kim GY, Luxton G, Koong A.

Med Dosim. 2006 Summer;31(2):91-112. Review.

PMID:
16690451
19.

From cellular to high-throughput predictive assays in radiation oncology: challenges and opportunities.

Bentzen SM.

Semin Radiat Oncol. 2008 Apr;18(2):75-88. doi: 10.1016/j.semradonc.2007.10.003. Review.

PMID:
18314062
20.

Adverse event reporting and developments in radiation biology after normal tissue injury: International Atomic Energy Agency consultation.

Chen Y, Trotti A, Coleman CN, Machtay M, Mirimanoff RO, Hay J, O'brien PC, El-Gueddari B, Salvajoli JV, Jeremic B.

Int J Radiat Oncol Biol Phys. 2006 Apr 1;64(5):1442-51.

PMID:
16414207

Supplemental Content

Support Center